Literature DB >> 27246858

Extended rhodamine photosensitizers for photodynamic therapy of cancer cells.

Kellie S Davies1, Michelle K Linder2, Mark W Kryman3, Michael R Detty4.   

Abstract

Extended thio- and selenorhodamines with a linear or angular fused benzo group were prepared. The absorption maxima for these compounds fell between 640 and 700nm. The extended rhodamines were evaluated for their potential as photosensitizers for photodynamic therapy in Colo-26 cells. These compounds were examined for their photophysical properties (absorption, fluorescence, and ability to generate singlet oxygen), for their dark and phototoxicity toward Colo-26 cells, and for their co-localization with mitochondrial-specific agents in Colo-26 and HUT-78 cells. The angular extended rhodamines were effective photosensitizers toward Colo-26 cells with 1.0Jcm(-2) laser light delivered at λmax±2nm with values of EC50 of (2.8±0.4)×10(-7)M for sulfur-containing analogue 6-S and (6.4±0.4)×10(-8)M for selenium-containing analogue 6-Se. The linear extended rhodamines were effective photosensitizers toward Colo-26 cells with 5 and 10Jcm(-2) of broad-band light (EC50's⩽2.4×10(-7)M).
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Extended rhodamines; Photodynamic therapy; Photosensitizers

Mesh:

Substances:

Year:  2016        PMID: 27246858     DOI: 10.1016/j.bmc.2016.05.033

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  Water-Soluble NIR Absorbing and Emitting Indolizine Cyanine and Indolizine Squaraine Dyes for Biological Imaging.

Authors:  William E Meador; Shane A Autry; Riley N Bessetti; Jacqueline N Gayton; Alex S Flynt; Nathan I Hammer; Jared H Delcamp
Journal:  J Org Chem       Date:  2020-02-21       Impact factor: 4.354

Review 2.  Photoactivity and optical applications of organic materials containing selenium and tellurium.

Authors:  Gabrielle C Hoover; Dwight S Seferos
Journal:  Chem Sci       Date:  2019-10-07       Impact factor: 9.825

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.